Ordinary Index Rebalancing in the Solactive Obesity Index | August 2019

In the ordinary rebalance the following composition will be implemented:

ABIOMED INC
ANGIODYNAMICS INC
APEX BIOTECHNOLOGY CORP
ARENA PHARMACEUTICALS INC
CARDIOVASCULAR SYSTEMS INC
CATO CORP-CLASS A
CRYOLIFE INC
DAVITA INC
DESTINATION XL GROUP INC
DEXCOM INC
EKF DIAGNOSTICS HOLDINGS PLC
ENDOLOGIX INC
ESPERION THERAPEUTICS INC
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED
FRESENIUS MEDICAL CARE AG & CO KGAA
HERBALIFE NUTRITION LTD
HUA MEDICINE
INSULET CORP
IRHYTHM TECHNOLOGIES INC
ITAMAR MEDICAL LTD
LEMAITRE VASCULAR INC
LEXICON PHARMACEUTICALS INC
LIFETECH SCIENTIFIC CORP
MADRIGAL PHARMACEUTICALS INC
MANNKIND CORP
MEDIFAST INC
MICROPORT SCIENTIFIC CORP
N BROWN GROUP PLC
NIPRO (NISSHO) CORP ORD
NOVO NORDISK AS CLASS B
POXEL SA
RESMED INC-CDI
RESVERLOGIX CORP
RHYTHM PHARMACEUTICALS INC
ROCKWELL MEDICAL INC
SENSEONICS HOLDINGS INC
TAIDOC TECHNOLOGY CORP
TANDEM DIABETES CARE INC
USANA HEALTH SCIENCES INC
WEIGHT WATCHERS INTL INC